Detalhe da pesquisa
1.
Superior Boosting of Neutralizing Titers Against Omicron SARS-CoV-2 Variants by Heterologous SCB-2019 Vaccine vs a Homologous Booster in CoronaVac-Primed Adults.
J Infect Dis
; 228(9): 1253-1262, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439701
2.
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
Lancet
; 399(10323): 461-472, 2022 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065705
3.
Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine Compared With 4 Approved Vaccines.
J Infect Dis
; 225(2): 327-331, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34888662
4.
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.
Lancet
; 397(10275): 682-694, 2021 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33524311
5.
Persistence of the Immune Responses and Cross-Neutralizing Activity With Variants of Concern Following 2 Doses of Adjuvanted SCB-2019 Coronavirus Disease 2019 Vaccine.
J Infect Dis
; 224(10): 1699-1706, 2021 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480575
6.
Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India.
BMC Infect Dis
; 14: 156, 2014 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24656175
7.
SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines.
Hum Vaccin Immunother
; 20(1): 2301632, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38206168
8.
Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: A phase 2/3, double-blind, randomized study.
Vaccine
; 41(13): 2253-2260, 2023 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868877
9.
Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study.
Vaccine
; 41(11): 1875-1884, 2023 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36781334
10.
Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12-17 year-old adolescents.
Hum Vaccin Immunother
; 19(1): 2206359, 2023 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226504
11.
Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study.
mSphere
; 6(4): e0056721, 2021 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34319129
12.
Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response.
Virus Res
; 277: 197839, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31837382
13.
Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic Areas.
Am J Trop Med Hyg
; 101(3): 708-715, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31392955
14.
Rapid fluorescent focus inhibition test optimization and validation: Improved detection of neutralizing antibodies to rabies virus.
J Immunol Methods
; 474: 112626, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31228423
15.
Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination.
Hum Vaccin Immunother
; 13(9): 2004-2016, 2017 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28598256
16.
Automated Imaging and Analysis of the Hemagglutination Inhibition Assay.
J Lab Autom
; 21(2): 287-96, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26464422
17.
Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial.
Clin Vaccine Immunol
; 23(3): 228-35, 2016 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26762363
18.
Influence of FcγRIIa-Expressing Cells on the Assessment of Neutralizing and Enhancing Serum Antibodies Elicited by a Live-Attenuated Tetravalent Dengue Vaccine.
Open Forum Infect Dis
; 2(4): ofv172, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719844
19.
Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults.
Vaccine
; 31(2): 327-33, 2013 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23153437
20.
Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development.
Am J Trop Med Hyg
; 88(5): 962-970, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23458954